Causal relationship between Alzheimer's disease and cardiovascular disease: a bidirectional Mendelian randomization analysis

被引:0
作者
Zhang, Fengjun [1 ]
Xian, Dexian [1 ]
Feng, Junchen [2 ]
Ning, Luning [1 ]
Jiang, Tianshou [3 ]
Xu, Wenchang [1 ]
Liu, Yuan [4 ]
Zhao, Qiong [4 ]
Peng, Min [4 ]
机构
[1] Shandong Univ Tradit Chinese Med, Coll Acupuncture & Massage, Jinan, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan, Peoples R China
[3] Lacey City Hosp, Dept Cardiovasc Med, Qingdao, Peoples R China
[4] Shandong First Med Univ, Shandong Prov Hosp, Dept Tradit Chinese Med, Jinan, Shandong, Peoples R China
来源
AGING-US | 2023年 / 15卷 / 17期
关键词
Alzheimer's disease (AD); cardiovascular disease (CVD); causality; bidirectional Mendelian randomization (MR); study; genome-wide association study (GWAS); HEART; RISK; ASSOCIATION; INSTRUMENTS; PREVENTION; LOCI; BETA;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Observational studies suggest that cardiovascular disease (CVD) increases the risk of developing Alzheimer's disease (AD). However, the causal relationship between the two is not clear. This study applied a two-sample bidirectional Mendelian randomization method to explore the causal relationship between CVD and AD. Genome-wide association study (GWAS) data from 46 datasets of European populations (21,982 cases of AD and 41,944 controls) were utilized to obtain genetic instrumental variables for AD. In addition, genetic instrumental variables for atrial fibrillation (AF), heart failure (HF), myocardial infarction (MI), coronary heart disease (CHD), angina pectoris (AP), and ischemic stroke (IS) (including large-artery atherosclerotic stroke [LAS] and cardioembolic stroke [CES]) were selected from GWAS data of European populations (P < 5E-8). The inverse variance weighting method was employed as the major Mendelian randomization analysis method. Genetically predicted AD odds ratios (OR) (1.06) (95% CI: 1.02-1.10, P = 0.003) were linked to higher AP analysis. A higher genetically predicted OR for CES (0.9) (95% CI 0.82-0.99, P = 0.02) was linked to a decreased AD risk. This Mendelian randomized study identified AD as a risk factor for AP. In addition, CES was related to a reduced incidence of AD. Therefore, these modifiable risk factors are crucial targets for preventing and treating AD.
引用
收藏
页码:9022 / 9040
页数:19
相关论文
共 42 条
[1]   Cognitive impairment and cardiovascular diseases in the elderly. A heart-brain continuum hypothesis [J].
Abete, Pasquale ;
Della-Morte, David ;
Gargiulo, Gaetano ;
Basile, Claudia ;
Langellotto, Assunta ;
Galizia, Gianluigi ;
Testa, Gianluca ;
Canonico, Vincenzo ;
Bonaduce, Domenico ;
Cacciatore, Francesco .
AGEING RESEARCH REVIEWS, 2014, 18 :41-52
[2]   Patients With Alzheimer Disease Have Altered Transmitral Flow Echocardiographic Analysis of the Vortex Formation Time [J].
Belohlavek, Marek ;
Jiamsripong, Panupong ;
Calleja, Anna M. ;
McMahon, Eileen M. ;
Maarouf, Chera L. ;
Kokjohn, Tyler A. ;
Chaffin, Teresa L. ;
Vedders, Linda J. ;
Garami, Zsolt ;
Beach, Thomas G. ;
Sabbagh, Marwan N. ;
Roher, Alex E. .
JOURNAL OF ULTRASOUND IN MEDICINE, 2009, 28 (11) :1493-1500
[3]   Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimer's Disease Mice [J].
Bian, Zhihong ;
Liu, Xia ;
Feng, Tian ;
Yu, Haibo ;
Hu, Xiao ;
Hu, Xinran ;
Bian, Yuting ;
Sun, Hongming ;
Tadokoro, Koh ;
Takemoto, Mami ;
Yunoki, Taijun ;
Nakano, Yumiko ;
Fukui, Yusuke ;
Morihara, Ryuta ;
Abe, Koji ;
Yamashita, Toru .
JOURNAL OF ALZHEIMERS DISEASE, 2022, 86 (01) :111-123
[4]   Inferring Causal Relationships Between Risk Factors and Outcomes from Genome-Wide Association Study Data [J].
Burgess, Stephen ;
Foley, Christopher N. ;
Zuber, Verena .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 19, 2018, 19 :303-327
[5]   Avoiding bias from weak instruments in Mendelian randomization studies [J].
Burgess, Stephen ;
Thompson, Simon G. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2011, 40 (03) :755-764
[6]   PROTECTIVE EFFECT OF APOLIPOPROTEIN-E TYPE-2 ALLELE FOR LATE-ONSET ALZHEIMER-DISEASE [J].
CORDER, EH ;
SAUNDERS, AM ;
RISCH, NJ ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
RIMMLER, JB ;
LOCKE, PA ;
CONNEALLY, PM ;
SCHMADER, KE ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
NATURE GENETICS, 1994, 7 (02) :180-184
[7]   Vascular Cognitive Impairment [J].
Dichgans, Martin ;
Leys, Didier .
CIRCULATION RESEARCH, 2017, 120 (03) :573-591
[8]   Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study [J].
Ding, Pingjian ;
Gorenflo, Maria P. ;
Zhu, Xiaofeng ;
Xu, Rong .
JOURNAL OF ALZHEIMERS DISEASE, 2023, 92 (03) :989-1000
[9]   Vascular contributions to Alzheimer's disease [J].
Eisenmenger, Laura B. ;
Peret, Anthony ;
Famakin, Bolanle M. ;
Spahic, Alma ;
Roberts, Grant S. ;
Bockholt, Jeremy H. ;
Johnson, Kevin M. ;
Paulsen, Jane S. .
TRANSLATIONAL RESEARCH, 2023, 254 :41-53
[10]   Lack of genetic support for shared aetiology of Coronary Artery Disease and Late-onset Alzheimer's disease [J].
Grace, Christopher ;
Clarke, Robert ;
Goel, Anuj ;
Farrall, Martin ;
Watkins, Hugh ;
Hopewell, Jemma C. .
SCIENTIFIC REPORTS, 2018, 8